US Broker Ratings

CRISPR Therapeutics AG (CRSP): Investor Outlook Reveals an 83% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the cutting edge of biotechnology, harnessing the transformative power of gene editing to tackle some of the most challenging human diseases. As a..

Organon & Co. (OGN) Stock Analysis: Is This Healthcare Giant a Hidden Gem or a Risky Bet?

As an investor in the healthcare sector, Organon & Co. (NYSE: OGN) presents an intriguing opportunity amidst a challenging market landscape. With its focus on women’s health solutions, including a..

ImmunityBio, Inc. (IBRX) Stock Report: A Promising Biotech with 73% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a notable player in the biotechnology sector, is drawing attention with its innovative approach to immunotherapy. Specializing in developing next-generation therapies to combat cancer and infectious..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Promising 18% Upside in the Biotech Space

Immunovant, Inc. (IMVT) presents a compelling case for investors looking to capitalize on the burgeoning biotechnology sector. With a market capitalization of $8.2 billion, this clinical-stage immunology company is making..

Vericel Corporation (VCEL) Stock Analysis: A Biotech Gem with 24.55% Potential Upside

Vericel Corporation (VCEL), a prominent player in the biotechnology sector, has been capturing the attention of investors with its robust growth trajectory and promising market potential. Headquartered in Burlington, Massachusetts,..

Veracyte, Inc. (VCYT) Stock Analysis: Impressive Revenue Growth Amidst Strong Buy Ratings

Veracyte, Inc. (VCYT) stands out as an intriguing player in the healthcare sector, particularly within the diagnostics and research industry. Based in South San Francisco, California, Veracyte operates as a..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 328% Upside in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based biotech firm specializing in biosimilar medicines, is capturing investor attention with its remarkable potential upside of 328.15%. As a player in the Healthcare sector, specifically within..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: An Investor’s Guide to 22.97% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its focus on rare disorders and a promising development pipeline. Based..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 62.3% Upside Potential in Biotech Innovation

Investors looking at the healthcare sector, particularly in the biotechnology industry, may find Zai Lab Limited (NASDAQ: ZLAB) a compelling opportunity. With a current market capitalization of $2.32 billion, this..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 22% Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a biopharmaceutical company focused on neuroscience, is currently capturing the attention of investors with its potential for substantial upside. Based in Burnaby, Canada, Xenon is..

Warby Parker Inc. (WRBY) Investor Outlook: Analyzing a 22.63% Potential Upside in the Healthcare Sector

Warby Parker Inc. (NYSE: WRBY), a trailblazer in the eyewear industry with a strong presence in both retail and e-commerce across the United States and Canada, is drawing significant attention..

PROCEPT BioRobotics Corporation (PRCT): Investor Outlook on a Potential 52% Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a prominent player in the healthcare sector, particularly within the medical devices industry, is drawing investor attention with its innovative surgical robotics technology and a..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Growth

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is attracting significant investor attention as it navigates the competitive biotechnology landscape, focusing on neurological and rare disease treatments. This article examines the company’s current..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 10.83% Potential Upside Amidst Healthcare Innovation

ICU Medical, Inc. (ICUI), a prominent player in the Healthcare sector specializing in Medical Instruments & Supplies, offers promising opportunities for investors seeking growth in the medical devices space. Headquartered..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking a 10.78% Potential Upside for Investors

For investors seeking exposure in the healthcare sector, Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity. With a market capitalization of $3.55 billion, this Boston-based medical technology firm stands out..

Perrigo Company plc (PRGO): Exploring a 55% Upside Potential Amidst High Dividend Yields

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, stands as a prominent player in the drug manufacturers industry, focusing on specialty and generic medications. Headquartered in Dublin,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a $10 Billion Valuation and Strategic Growth in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing investor interest with its strategic focus on genetic medicines targeting diseases with high unmet medical needs...

Guardant Health, Inc. (GH) Stock Analysis: Unpacking a 48% Revenue Growth in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) has emerged as a formidable player in the diagnostics and research segment of the healthcare industry. With a market capitalization of $20.67 billion, this precision..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 33.81% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has been a topic of interest among investors due to its extensive range of over-the-counter (OTC) health..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth with a 15.59% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the drug manufacturing industry for specialty and generic products, presents an intriguing opportunity for investors..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds